Cargando…

Implications of Fragment-Based Drug Discovery in Tuberculosis and HIV

Tuberculosis (TB) remains a global health problem and the emergence of HIV has further worsened it. Long chemotherapy and the emergence of drug-resistance strains of Mycobacterium tuberculosis as well as HIV has aggravated the problem. This demands urgent the need to develop new anti-tuberculosis an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mallakuntla, Mohan Krishna, Togre, Namdev S., Santos, Destiny B., Tiwari, Sangeeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692459/ https://www.ncbi.nlm.nih.gov/pubmed/36422545 http://dx.doi.org/10.3390/ph15111415

Ejemplares similares

Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges
por: Togre, Namdev S., et al.
Publicado: (2022)

Harnessing Immune Evasion Strategy of Lymphatic Filariae: A Therapeutic Approach against Inflammatory and Infective Pathology
por: Bhoj, Priyanka, et al.
Publicado: (2022)

Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
por: McAulay, Kirsten, et al.
Publicado: (2022)

Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
por: Konaklieva, Monika I., et al.
Publicado: (2023)

Native Mass Spectrometry in Fragment-Based Drug Discovery
por: Pedro, Liliana, et al.
Publicado: (2016)

Applications of (19)F-NMR in Fragment-Based Drug Discovery
por: Norton, Raymond S., et al.
Publicado: (2016)

Fragment‐based drug discovery—the importance of high‐quality molecule libraries
por: Bon, Marta, et al.
Publicado: (2022)

Fragment approaches in structure-based drug discovery
por: Hubbard, Roderick E.
Publicado: (2008)

Is it time for biocatalysis in fragment-based drug discovery?
por: Ramsden, Jeremy I., et al.
Publicado: (2020)

In Silico Strategies in Tuberculosis Drug Discovery
por: Macalino, Stephani Joy Y., et al.
Publicado: (2020)

Alcohol and e-cigarette damage alveolar-epithelial barrier by activation of P2X7r and provoke brain endothelial injury via extracellular vesicles
por: Mekala, Naveen, et al.
Publicado: (2023)

Fragment-Sized Thiazoles in Fragment-Based Drug Discovery Campaigns: Friend or Foe?
por: Proj, Matic, et al.
Publicado: (2022)

Application of Fragment-Based Drug Discovery to Versatile Targets
por: Li, Qingxin
Publicado: (2020)

Fragment-based drug discovery: opportunities for organic synthesis
por: St. Denis, Jeffrey D., et al.
Publicado: (2020)

Targeting the ubiquitin system by fragment-based drug discovery
por: Kennedy, Cassandra, et al.
Publicado: (2022)

Fragment-based screening with natural products for novel anti-parasitic disease drug discovery
por: Liu, Miaomiao, et al.
Publicado: (2019)

Fragments and hot spots in drug discovery
por: Vajda, Sandor, et al.
Publicado: (2015)

Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production
por: Bayart, Caroline, et al.
Publicado: (2022)

ACFIS: a web server for fragment-based drug discovery
por: Hao, Ge-Fei, et al.
Publicado: (2016)

Dynamic template-assisted strategies in fragment-based drug discovery
por: Schmidt, Marco F., et al.
Publicado: (2009)

Bioanalysis in drug discovery and development
por: Pandey, Saurabh, et al.
Publicado: (2010)

Target Identification in Anti-Tuberculosis Drug Discovery
por: Capela, Rita, et al.
Publicado: (2023)

Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis
por: Kingdon, Alexander D.H., et al.
Publicado: (2021)

Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening
por: Grzelak, Edyta M., et al.
Publicado: (2019)

Current perspectives in fragment-based lead discovery (FBLD)
por: Lamoree, Bas, et al.
Publicado: (2017)

Transglycosylation by a chitinase from Enterobacter cloacae subsp. cloacae generates longer chitin oligosaccharides
por: Mallakuntla, Mohan Krishna, et al.
Publicado: (2017)

Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach
por: Ejalonibu, Murtala A., et al.
Publicado: (2021)

Michael Adduct of Sulfonamide Chalcone Targets Folate Metabolism in Brugia Malayi Parasite
por: Bhoj, Priyanka S., et al.
Publicado: (2023)

Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery
por: Ghosh, Kalyan, et al.
Publicado: (2021)

Fragment-based covalent ligand discovery
por: Lu, Wenchao, et al.
Publicado: (2021)

Process of Fragment-Based Lead Discovery—A Perspective from NMR
por: Ma, Rongsheng, et al.
Publicado: (2016)

Allosteric Tuning of Caspase‐7: A Fragment‐Based Drug Discovery Approach
por: Vance, Nicholas R., et al.
Publicado: (2017)

Cycloaddition Strategies for the Synthesis of Diverse Heterocyclic Spirocycles for Fragment‐Based Drug Discovery
por: King, Thomas A., et al.
Publicado: (2019)

Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
por: Mureddu, Luca G., et al.
Publicado: (2022)

Fragment-based drug discovery of small molecule ligands for the human chemokine CCL28
por: Zhou, Angela L., et al.
Publicado: (2023)

Fragment Library of Natural Products and Compound Databases for Drug Discovery †
por: Chávez-Hernández, Ana L., et al.
Publicado: (2020)

In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
por: de Souza Neto, Lauro Ribeiro, et al.
Publicado: (2020)

Tuberculosis: Past, present and future of the treatment and drug discovery research
por: Bendre, Ameya D., et al.
Publicado: (2021)

Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery
por: Molloy, Antonia, et al.
Publicado: (2021)

Advances in Diagnostics and Drug Discovery against Resistant and Latent Tuberculosis Infection
por: Shleider Carnero Canales, Christian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kkr436955hnb4c8dnv4p0gilb4